Surmodics | 营业费用

金融业

USD

USD 178.56M

现金及等价物

USD 36.12M

USD 33.03M

USD 81.3M

USD 20.54M

USD 29.55M

股息收益率

0

USD -322K

USD 1.53M

376

EPS每股收益

USD -0.25

股本和储备

USD 118.9M

USD -11.54M

债务利息支出

USD 884K

USD 29.55M

USD 393.5M

USD -11.54M

USD -245.35M

USD -5.65M

普通股股本

USD 716K

386.18

USD -7.51M

USD 29.92M

销售和管理费用

USD 14.58M

USD 15.17M

贸易债权人

USD 2.79M

应收帐款人

USD 23.27M

	营业费用	更改		日
Abbott	USD 9.21B		17M	2025-12
Align Technology	USD 822.85M		11.8M	2025-12
Anika Therapeutics	USD 146.8M		867K	2025-09
Arrowhead Research	USD 223.22M		10.86M	2025-12
Baxter International	USD 2.63B		95.8M	2025-09
Boston Scientific	USD 4.04B		18M	2025-12
EDAP TMS	EUR 21.81M		2.26M	2025-06
Edwards Lifesciences	USD 1.2B		71.3M	2025-12
Haemonetics	USD 134.99M		1.26M	2025-12
Heron Therapeutics	USD 38.47M		4M	2024-09
J&J	USD 18.97B		2.38B	2025-12
Merit Medical Systems	USD 341.54M		6.11M	2025-09
Mesa Laboratories	USD 33.98M		2.03M	2024-12
Nektar Therapeutics	USD 85.09M		109.3M	2025-09
Option Care Health	USD 1.35B		17.13M	2025-09
Stryker	USD 5.2B		505M	2025-12
Surmodics	USD -245.35M		363.49M	2024-09
Trinity Biotech	USD 14.82M		7.81M	2025-09

Surmodics 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.